Insights On Clinical Technologies
Making The Complex Easy By Offering Better Data, Faster
Make the complex easy by providing better data, faster. In our latest video installment, hear Justine Pierson explain the easily configured & flexible aspects of our solution suite that simplifies the complexity of managing any study.
Unflattening The Curve: Minimize The Impact To Patients Who Depend On Your Successful Clinical Trial
Similar to how the response and immediate action to the “Flattening the Curve” movement in 2020 was executed to dramatically lessen the severity and impact of the pandemic on millions of lives, the actions and strategies implemented in today’s clinical studies will impact how patients in current trials will get their investigational treatments. Without a proactive and comprehensive strategy in place to manage clinical trials during the pandemic, consequences may be severe –especially for those that need the treatment the most.
Device Strategy For eCOA: BYOD Or Provisioned?
By asking the right questions, and understanding and preparing for all the variables, you can help a sponsor successfully implement the modality that increases patient compliance while minimizing missing data and risks to data integrity throughout the life of a study, even a long-term study.
A Comparison Between Document Management Systems (DMS) And Component Content Management Systems (CCMS) For Pharma
To mitigate risk, ensure patient safety, meet regulatory compliance standards, and reduce cycle times for faster drug-to-market, learn how pharma companies are continually looking for new technologies and processes.
How Can You Help Sites Manage Training And Education On DCT Technologies?
When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.
Paving The Way Towards Carbon Neutral eCOA Trials
The timing to introduce additional carbon-efficient solutions to clinical trials is now. This article explores on how to improve the eCOA trials carbon footprint.
elluminate Statistical Computing Environment
Enhance your statistical analyses, automate workflows, and increase programming and analysis efficiencies with the elluminate Statistical Computing Environment (SCE).
When Do Life Sciences Companies Rely Most On Technology?
In this article, consider survey findings that illustrate how life science companies view and treat technology and how they can be assisted in reaching their goals.
Strategies To Support Flexibility, Ensure Data Quality, And Preserve Data Privacy
Learn how clinical teams can better identify and mitigate those risks and the strategies to support flexibility in data collection, guarantee data quality, and preserve data privacy.
How To Address Early Obstacles In Phase I
What steps can sponsors and CROs take to position their early-stage studies for success and expedite their final market approval? In this article, we’ll explore three obstacles that researchers face early in phase I studies, as well as some insight into how the right eClinical suite can overcome those challenges.